Public Health Trace

Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters

Drug Recall Terminated Historical recordClass I

Adventure First Aid 1.0, First Aid Kit, containing Easy Care first aid After Burn Cream 0.9 g packets, Product # 0120-0213

by GFA Production Xiamen Co. Ltd.

Reason: Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.
Recall initiated: December 23, 2022
Reported by FDA: February 8, 2023
Distribution: Nationwide and Canada.

View recall →

Drug Recall Terminated Historical recordClass I

Adventure Marine 150, First Aid Kit, containing Easy Care first aid After Burn Cream 0.9 g packets, Product # 1015-0150

by GFA Production Xiamen Co. Ltd.

Reason: Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.
Recall initiated: December 23, 2022
Reported by FDA: February 8, 2023
Distribution: Nationwide and Canada.

View recall →

Drug Recall Terminated Historical recordClass I

Easy Care first aid Burn Cream (benzalkonium chloride 0.13% and lidocaine hydrochloride 0.5%), 0.9 g (0.03 oz) packets packaged in boxes of 10, Treatment for Burns, Made in China for Adventure Ready Brands, 944 Industrial Park Rd., Littleton, NH 03561, NDC 90107-0210, Product # 9999-1515

by GFA Production Xiamen Co. Ltd.

Reason: Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.
Recall initiated: December 23, 2022
Reported by FDA: February 8, 2023
Distribution: Nationwide and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

VORICONAZOLE 10MG/ML (10ML DROPPER) OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

VITAMIN D3-AQUEOUS- 10,000IU/ML (1ML VIAL) INJECTABLE; VITAMIN D3-PF-ETHYL OLEATE- 50,000IU/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

TESTOSTERONE 3% (4GM TUBE) OPHTH OINTME TESTOSTERONE CYP/ANASTROZOLE-GS OIL- 200MG/0.5MG/ML (3.5ML VIAL) INJECTABLE TESTOSTERONE CYP/ANASTROZOLE-GS OIL- 200MG/1MG/ML (1.5ML VIAL) INJECTABLE TESTOSTERONE CYP/ANASTROZOLE-GS OIL- 200MG/1MG/ML (3ML VIAL) INJECTABLE TESTOSTERONE CYP/ANASTROZOLE-GS OIL- 200MG/1MG/ML (4ML VIAL) INJECTABLE TESTOSTERONE CYP/ESTRADIOL CYP-SS OIL- 50MG/2MG/ML (1.5ML VIAL) INJECTABLE TESTOSTERONE CYP/ESTRADIOL CYP-SS OIL- 50MG/2MG/ML (1ML VIAL) INJECTABLE TESTOSTERONE CYP/ESTRADIOL CYP-SS OIL- 50MG/2MG/ML (2ML VIAL) INJECTABLE TESTOSTERONE CYP/PROP(80/20)-GS OIL- 200MG/ML (5ML VIAL) INJECTABLE TESTOSTERONE CYP-CS OIL-PF- 80MG/ML (0.7ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 100MG/ML (1.2ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 150MG/ML (3.5ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 150MG/ML (4ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 200MG/ML (2.5ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 200MG/ML (3.5ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 200MG/ML (3ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 200MG/ML (4ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 20MG/ML (1.5ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 20MG/ML (2ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 25MG/ML (1.5ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 25MG/ML (2ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 25MG/ML (3.5ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 300MG/ML (5ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 50MG/ML (1.5ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 50MG/ML (1ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 50MG/ML (2.5ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 50MG/ML (3.5ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 75MG/ML (1.5ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 75MG/ML (2ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 80MG/ML (1.5ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL- 80MG/ML (1ML VIAL) INJECTABLE TESTOSTERONE CYP-GS OIL-PF- 75MG/ML (1ML VIAL) INJECTABLE TESTOSTERONE CYP-OLIVE OIL- 50MG/ML (2ML VIAL) INJECTABLE TESTOSTERONE CYP-SS OIL- 125MG/ML (5ML VIAL) INJECTABLE TESTOSTERONE CYP-SS OIL- 200MG/ML (5ML VIAL) INJECTABLE TESTOSTERONE CYP-SS OIL- 50MG/ML (2ML VIAL) INJECTABLE TESTOSTERONE CYP-SS OIL-PF- 80MG/ML (1ML VIAL) INJECTABLE TESTOSTERONE ENAN-GS OIL-PF- 300MG/ML (0.4ML VIAL) INJECTABLE TESTOSTERONE-PF- 50MG/ML (5%) (1ML DROPTAINERS) OPHTHALMIC, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

SEMAGLUTIDE 0.5MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 1MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 2MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 4MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 5.4MG/ML (0.5ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

PROSTAGLANDIN (PE1) 45MCG (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 17MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 20MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 22.5MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 23MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 30MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 40MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 44.5MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 45MCG/ML (3ML VIAL) INJECTABLE PROSTAGLANDIN E1 50MCG/ML (1ML VIAL) INJECTION PROSTAGLANDIN E1 60MCG/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

PROGESTERONE-GS OIL- 100MG/ML (2ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

POLYHEXAMETHYLENE BIGUANIDE 0.2MG/ML (0.2%) (10ML DROPTAINER) OPTH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

POLIDOCANOL 50MG/ML (5%) (30ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

PHOSPHATIDYLCHOLINE/DEOXYCHOLIC ACID (10ML VIAL) 50MG/50MG/ML (5%/5%) INJECTABLE; Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

NADH 10MG/ML (10ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

MITOMYCIN 0.4MG/ML (1ML DROPTAINER) OPH SOLUTION; MITOMYCIN 0.4MG/ML (1ML VIAL) OPH SOLUTION; MITOMYCIN 0.4MG/ML (4ML VIAL) OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

MITOMYCIN 0.2MG/ML (1ML DROPTAINER) OPH SOLUTION; MITOMYCIN 0.2MG/ML (1ML VIAL) OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

METHYLCOBALAMIN 12.5MG/ML (1ML VIAL) INJECTABLE METHYLCOBALAMIN 25MG/ML (1.2ML VIAL) INJECTABLE; METHYLCOBALAMIN 3MG/ML (1ML VIAL) INJECTABLE; METHYLCOBALAMIN 5MG/ML (0.2ML VIAL) INJECTABLE; METHYLCOBALAMIN 5MG/ML (1ML VIAL) INJECTABLE; METHYLCOBALAMIN-PF- 12.5MG/ML (1ML VIAL) INJECTABLE; METHYLCOBALAMIN-PF- 25MG/ML (0.5ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

METHOTREXATE INTRAVITREAL (1ML VIAL) 4MG/ML (400MCG/0.1ML) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

MAGNESIUM CHLORIDE HEXAHYDRATE-PF- 200MG/ML (5ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

LIDOCAINE-PF- 5% (5ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

LEVEMIR-STS- 100U/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Data last updated: November 3, 2026 ET

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.